Filipa Bica Simões
Filipa Bica Simões publishes mostly in Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Cystic Fibrosis Research Advances and Systemic Sclerosis and Related Diseases.
- World rank
- #4,880,715 of 7,710,434 ranked researchers
- Rank in Denmark
- #33,420 of 43,819
- Works
- 26
- Citations
- 137
- Citations per work
- 5.3
What does Filipa Bica Simões research?
Filipa Bica Simões's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (16%), Engineering (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1659.9%
- Medicine1659.9%
- Everything else518.6%
- Life Sciences415.8%
- Physical Sciences15.7%
- Engineering15.7%
- 1Pulmonary and Respiratory Medicine47% of their works
- 2Molecular Biology13% of their works
- 3Pathology and Forensic Medicine7% of their works
- 4Cardiology and Cardiovascular Medicine6% of their works
- 5Biomedical Engineering6% of their works
- 6Genetics3% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cystic Fibrosis Research Advances
- Systemic Sclerosis and Related Diseases
- Cardiac Fibrosis and Remodeling
- Pulmonary Hypertension Research and Treatments
- Connective Tissue Growth Factor Research
- Neonatal Respiratory Health Research
- Bacterial biofilms and quorum sensing
Which keywords describe Filipa Bica Simões's research?
The keywords of their largest research topics: Fibrosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Endothelial Dysfunction, TGF-ß Signaling, Pulmonary Hypertension, CFTR and Cystic Fibrosis.
- Bacteria
- Connective Tissue Growth Factor
- Bronchopulmonary Dysplasia
- Inflammatory Response
- Cardiac Remodeling
- Autoantibodies
- Cystic Fibrosis
- Pulmonary Hypertension
- Endothelial Dysfunction
- Idiopathic Pulmonary Fibrosis
- Fibrosis
- Interstitial Lung Disease
- TGF-ß Signaling
- CFTR
- Extracellular Matrix
- Systemic Sclerosis
- Echocardiography
- Right Heart Assessment
- CCN Family
- Preterm Infants
- Biofilms
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Fibrosis274 topics
- Idiopathic Pulmonary Fibrosis151 topic
- Interstitial Lung Disease151 topic
- Endothelial Dysfunction92 topics
- TGF-ß Signaling82 topics
- Pulmonary Hypertension72 topics
- CFTR61 topic
- Cystic Fibrosis61 topic
- Extracellular Matrix62 topics
- Autoantibodies51 topic
- Systemic Sclerosis51 topic
- Cardiac Remodeling41 topic
- Echocardiography41 topic
- Inflammatory Response41 topic
- Right Heart Assessment41 topic
- Bronchopulmonary Dysplasia31 topic
- CCN Family31 topic
- Connective Tissue Growth Factor31 topic
- Preterm Infants31 topic
- Bacteria21 topic
- Biofilms21 topic
Where does Filipa Bica Simões work?
Filipa Bica Simões's main affiliation in the publication record is Nordic Bioscience (Denmark), Denmark.
How many publications and citations does Filipa Bica Simões have?
OpenAlex counts 26 works and 137 citations for Filipa Bica Simões, an h-index of 5, ranking #4,880,715 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Filipa Bica Simões. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.